Authors

1. Aschenbrenner , Diane S.

Abstract

• Generic versions of the central nervous system stimulant lisdexamfetamine dimesylate (Vyvanse) capsules and chewable tablets are now approved to treat attention deficit–hyperactivity disorder in children ages six years and older and moderate to severe binge-eating disorder in adults.
• The Food and Drug Administration offers online content that can be used in patient education about generics.